Kindstar Globalgene Technology, Inc. (Kindstar Global) disclosed that it repurchased 21,500 ordinary shares on 9 July 2026 via on-market transactions on the Hong Kong Stock Exchange. Purchase prices ranged between HK$0.95 and HK$0.97 per share, delivering a volume-weighted average cost of HK$0.95 per share and an aggregate cash outlay of HK$20.44 million.

Following the transaction, Kindstar Global’s outstanding share count fell marginally by 0.00208% to 1.03378 billion shares. Treasury stock increased to 7.55 million shares, while the company’s total issued share capital remained unchanged at 1.04133 billion shares.

The buyback forms part of the mandate approved on 5 June 2026, which authorises the repurchase of up to 103.43 million shares. To date, 485,500 shares—equivalent to 0.05% of the issued share base at the time of approval—have been acquired under this mandate. A moratorium on new share issues or treasury share disposals runs until 8 August 2026, in line with Hong Kong Stock Exchange rules.

Management confirmed that all repurchases complied with the HKEX Main Board Rules and the company’s April 2026 explanatory statement.